Send the following on WhatsApp
Continue to ChatRoche details Alecensa data that may shift the drug to post-surgery ALK-positive lung cancer: #ESMO23 https://invesbrain.com/roche-details-alecensa-data-that-may-shift-the-drug-to-post-surgery-alk-positive-lung-cancer-esmo23/